Baseline imaging markers that favor treatment response of thrombectomy |
Treatment-Related Acute Imaging Target (TRAIT) for thrombectomy |
|
Imaging selection of patients for acute reperfusion trials (not limited to endovascular therapies): Recommendations |
Imaging for defining the Treatment Relevant Acute Imaging Target (TRAIT) is highly recommended for patient selection
Additional time spent acquiring additional imaging information must be balanced against risk of delay in initiating reperfusion therapies
Pre-randomization vascular imaging should be obtained in acute endovascular trials. This would usually be done by CTA or MRA. Catheter angiography is included as a method for patient selection but it is understood that it is not likely the initial method for patient selection in a clinical trial
Vascular, core, mismatch and collateral imaging each have added value for identifying TRAIT and enriching sample toward greatest effect size. More than one imaging method and threshold criterion is acceptable for these purposes, but should be standardized within a trial
Particularly in phase II trials with small sample sizes, both vascular and advanced tissue imaging may offer insights into patient populations that cannot be obtained from clinical data alone, and are recommended to assist characterization of patient populations and improve understanding of experimental therapies
|
Proposed imaging methods for patient selection |
TRAIT |
Proposed imaging methods |
Artery occlusion |
CTA
MRA
Catheter angiography
|
Core |
|
Mismatch |
|
Cerebral collaterals |
|